EVGN - エボジェン (Evogene Ltd.) エボジェン

 EVGNのチャート


 EVGNの企業情報

symbol EVGN
会社名 Evogene Ltd (エボジェン)
分野(sector) Basic Industries   素材
産業(industry) Agricultural Chemicals  
業種    原材料・素材(Materials)
概要 事業概要 --   エボジェンはイスラエルの植物ゲノム会社。バイオテクノロジ―と高度育種法を駆使し、種子の成長と生産性の向上を促す包括的なソリュ―ションを影響。トウモロコシ、大豆、小麦、米等の主要作物の生産性の向上、および耐乾性と耐病性強化などの形質を付与する育種技術の開発に向けて、農業従事者と戦略的に業務提携を行う。   Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. It operates through the following segments: Agriculture, Industry, and Human. The Agriculture segment engages in the development of seed traits, agrochemical products, and agrobiological products to improve plant performance. The Industry segment engages in the development of castor bean seeds to serve as a feedstock source for biofuel and other industrial uses. The Human segment engages in the discovery and development of human microbiome-based therapeutics. The company was founded by Amir Barzilay and Hagai Karchi on October 10, 1999 and is headquartered in Rehovot, Israel.
本社所在地 13 Gad Feinstein Street Park Rehovot P.O.B 2100 Rehovot 7612002 ISR
代表者氏名
代表者役職名
電話番号
設立年月日 2000年
市場名 NASDAQ National Market System
ipoyear ―年
従業員数 165人
url www.evogene.com
nasdaq_url https://www.nasdaq.com/symbol/evgn
adr_tso
EBITDA EBITDA ー
終値(lastsale) 2.95
時価総額(marketcap) 75975176.15
時価総額 時価総額 ―
売上高 売上高 --
企業価値(EV) 企業価値(EV) ー
当期純利益 当期純利益 --
決算概要 決算概要 --

 EVGNのテクニカル分析


 EVGNのニュース

   Biomica Announces Initiation of Large-Scale Production of Live Bacterial Product (LBP) Candidate Consortium in its Immuno-Oncology Program  2020/10/13 11:00:00 PR Newswire
REHOVOT, Israel, Oct. 13, 2020 /PRNewswire/ -- Biomica, an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), announced today the advancement to large-scale production of BMC128, its Live…
   The Daily Biotech Pulse: FDA Nod For Pfizer, Sorrento's COVID-19 Antibody Animal Data, Orphazyme's Wall Street Debut  2020/09/29 11:47:04 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 28) 10X Genomics Inc (NASDAQ: TXG ) Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) Beigene Ltd (NASDAQ: BGNE ) Cardiff Oncology Inc (NASDAQ: CRDF ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) Evogene Ltd (NASDAQ: EVGN ) Fate Therapeutics Inc (NASDAQ: FATE ) Guardant Health Inc (NASDAQ: GH ) InVitae Corp (NYSE: NVTA ) Kaleido Biosciences Inc (NASDAQ: KLDO ) Kura Oncology Inc (NASDAQ: KURA ) Lantern Pharma Inc. (NASDAQ: LTRN ) Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA ) Pacific Biosciences of California Inc (NASDAQ: PACB ) Prelude Therapeutics Incorporated (NASDAQ: PRLD ) (listed Thursday) Seattle Genetics, Inc. (NASDAQ: SGEN ) Shockwave Medical Inc (NASDAQ: SWAV Turning Point Therapeutics Inc (NASDAQ: T )PTX) Twist Bioscience Corp (NASDAQ: TWST ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Sept. 28) Abeona Therapeutics Inc (NASDAQ: ABEO ) (announced departure of CEO and board members stepping down) AnPac Bio-Medical Science Co Ltd – ADR (NASDAQ: ANPC ) Fusion Pharmaceuticals Inc (NASDAQ: FUSN ) Gritstone Oncology Inc (NASDAQ: GRTS ) Happiness Biotech Group Ltd (NASDAQ: HAPP ) Hoth Therapeutics Inc (NASDAQ: HOTH ) Neos Therapeutics Inc (NASDAQ: NEOS ) Odonate Therapeutics Inc (NASDAQ: ODT ) Oncternal Therapeutics Inc (NASDAQ: ONCT ) Orchard Therapeutics PLC – ADR (NASDAQ: ORTX ) (announced EMA's Priority Medicines designation for gene therapy candidate OTL-203 in the treatment of mucopolysaccharidosis type I) PainReform Ltd (NASDAQ: PRFX ) Radius Health Inc (NASDAQ: RDUS ) Silence Therapeutics ADR Representing 3 Ord Shs (NASDAQ: SLN ) Teligent Inc (NEW JERSEY) (NASDAQ: TLGT ) Tricida Inc (NASDAQ: TCDA ) Stocks In Focus Pfizer's Rheumatoid Arthritis Drug Gets Label Expansion Pfizer Inc.
   62 Biggest Movers From Friday  2020/09/21 09:17:02 Benzinga
Gainers COMPASS Pathways Plc (NASDAQ: CMPS ) shares jumped 70.6% to close at $29.00 on Friday after pricing its IPO at $17 per share. Cassava Sciences, Inc. (NASDAQ: SAVA ) shares climbed 42% to close at $10.07 on Friday following news of two insiders buying stock Thursday even for a total of about 225,000 shares. Westport Fuel Systems Inc. (NASDAQ: WPRT ) surged 38.9% to close at $2.25 after the company announced its Weichai Westport joint venture received certification from the Ministry of Ecology and Environment of China for its 12-liter engine equipped with the HPDI 2.0 fuel system. Contura Energy, Inc. (NYSE: CTRA ) gained 35.7% to close at $8.14. Adicet Bio Inc (NASDAQ: ACET ) rose 32.8% to close at $21.40. Adicet Bio reported inducement grant under Nasdaq Listing Rule 5635(C)(4). Unity Software Inc. (NYSE: U ) gained 31.4% to close at $68.35 after the company priced its IPO at $52 per share. Renren Inc. (NYSE: RENN ) shares jumped 29.1% to close at $2.93 on Friday. ProPhase Labs, Inc. (NASDAQ: PRPH ) gained 29% to close at $3.87 after reporting a $10 million unsecured debt financing.
   Biomica Announces Positive Pre-Clinical Results in its Immuno-Oncology Program  2020/09/08 11:00:00 PR Newswire
REHOVOT, Israel, Sept. 8, 2020 /PRNewswire/ -- Biomica Ltd., an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), today announced positive pre-clinical in-vivo results in its…
   The Week In Cannabis: Stocks Down, Moves In Latin America, Financings, And More  2020/09/04 19:10:58 Benzinga
This was a bad week for markets in general, and cannabis was no exception. Over the five trading days of the week: The ETFMG Alternative Harvest ETF (NYSE: MJ ): lost more than 6% The AdvisorShares Pure Cannabis ETF (NYSE: YOLO ): was down almost 9% The Cannabis ETF (NYSE: THCX ): dropped 9%. The Amplify Seymour Cannabis ETF (NYSE: CNBS ): lost 7.5%. The SPDR S&P 500 ETF Trust (NYSE: SPY ) was down 3.4%. We also saw the AdvisorShares Pure US Cannabis ETF (NYSE: MSOS ) start trading on Wednesday, becoming the first U.S.-listed active ETF focused solely on American cannabis companies, and Item 9 Labs Corp. (OTC: INLB ) begin trading on the OTCQX on Monday. Cannabis SaaS platform Headset secured $3.2 million in financing through a bridge round led by Canopy Rivers Inc. (OTC: CNPOF ). AeroPay teamed up with Safe Harbor Private Banking on a payments service for CBD, cannabis and non-plant touching ancillary service businesses. Payment processing company Hypur announced a new partnership with leading credit union GFA Federal Credit Union to provide consumers with digital, contactless payments for in-store cannabis orders, including curbside pickup and deliveries in Massachusetts.
   Evogene to Participate in CRISPR-IL Consortium to Provide End-to-End Artificial Intelligence System for Genome-Editing  2020/06/03 11:00:00 PR Newswire
REHOVOT, Israel, June 3, 2020 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading computational biology company targeting to revolutionize life-science product development across several market segments, announced today its participation in the CRISPR-IL consortium. The…
   The Week In Cannabis: A Mixed Bag Leads Marijuana Stocks To Underperform  2020/05/30 18:38:01 Benzinga Feeds
This week brought a mixed bag of news for the cannabis industry. Aphria Inc (NYSE: APHA ) announced it will transfer its stock from the New York Stock Exchange to the Nasdaq exchange after the market close June 5, and a long list of earnings reports, some better than others. Cresco Labs Inc. (CSE: CL) (OTC: CRLBF ) had a great week with numerous store-opening announcements. The company also reported first-quarter revenue of $66.4 million, up 60% from the previous quarter. “In Q1 we built, staffed, integrated, and refined our operations in the largest and most important cannabis markets in the U.S.,” said the company's co-founder and CEO Charles Bachtell. TerrAscend Corp. (CSE: TER) (OTC: TRSSF ) reported net sales of CA$34.8 million (US$25.2 million) for the first quarter of 2020, up 34% quarter-over-quarter and 139% year-over-year. The Toronto-based company reached a positive adjusted EBITDA of CA$4.9 million versus a loss of CA$5.5 million in the corresponding quarter last year. Amid restructuring efforts, Canopy Growth Corp. (TSX: WEED) (NYSE: CGC ) reported a fourth-quarter net loss of CA$1.3 billion ($946.4 million), up from the loss of CA$347.5 million it posted for the same quarter a year ago.
   Evogene Posts Q1 Results, Suffers 67% YoY Revenue Decline  2020/05/26 19:31:02 Benzinga Feeds
Biotechnology company Evogene Ltd. (NASDAQ: EVGN ) released Tuesday its financial results for the first quarter of 2020. The Israel-based company, which is oriented toward improving crop quality and productivity, saw the quarter's year-over-year revenue decrease by roughly 67%, from $300,000 in 2019 to $100,000. The first quarter of 2020 showed a significant decline compared to the same period in the last year. Evogene has been struggling for months as its fourth quarter financial update reported downturns as well. Here's a breakdown of what the earnings report for the first quarter showed: Gross profit was $36 000, compared to a gross … Full story available on Benzinga.com
   Evogene Reports First Quarter 2020 Financial Results  2020/05/26 11:00:00 PR Newswire
REHOVOT, Israel, May 26, 2020 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading computational biology company targeting to revolutionize life-science product development across several market segments, announced today its financial results for the first quarter, ended…
   Evogene : Launches its New Branding to Reflect the Company's Expanded Vision and New Business Model | MarketScreener  2020/05/20 11:19:09 MarketScreener
Rehovot, Israel - May 20, 2020- Evogene Ltd. , a leading computational biology company targeting to revolutionize life-science product development across several market segments,… | May 20, 2020
   Evogene to Participate in CRISPR-IL Consortium to Provide End-to-End Artificial Intelligence System for Genome-Editing  2020/06/03 11:00:00 PR Newswire
REHOVOT, Israel, June 3, 2020 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading computational biology company targeting to revolutionize life-science product development across several market segments, announced today its participation in the CRISPR-IL consortium. The…
   The Week In Cannabis: A Mixed Bag Leads Marijuana Stocks To Underperform  2020/05/30 18:38:01 Benzinga Feeds
This week brought a mixed bag of news for the cannabis industry. Aphria Inc (NYSE: APHA ) announced it will transfer its stock from the New York Stock Exchange to the Nasdaq exchange after the market close June 5, and a long list of earnings reports, some better than others. Cresco Labs Inc. (CSE: CL) (OTC: CRLBF ) had a great week with numerous store-opening announcements. The company also reported first-quarter revenue of $66.4 million, up 60% from the previous quarter. “In Q1 we built, staffed, integrated, and refined our operations in the largest and most important cannabis markets in the U.S.,” said the company's co-founder and CEO Charles Bachtell. TerrAscend Corp. (CSE: TER) (OTC: TRSSF ) reported net sales of CA$34.8 million (US$25.2 million) for the first quarter of 2020, up 34% quarter-over-quarter and 139% year-over-year. The Toronto-based company reached a positive adjusted EBITDA of CA$4.9 million versus a loss of CA$5.5 million in the corresponding quarter last year. Amid restructuring efforts, Canopy Growth Corp. (TSX: WEED) (NYSE: CGC ) reported a fourth-quarter net loss of CA$1.3 billion ($946.4 million), up from the loss of CA$347.5 million it posted for the same quarter a year ago.
   Evogene Posts Q1 Results, Suffers 67% YoY Revenue Decline  2020/05/26 19:31:02 Benzinga Feeds
Biotechnology company Evogene Ltd. (NASDAQ: EVGN ) released Tuesday its financial results for the first quarter of 2020. The Israel-based company, which is oriented toward improving crop quality and productivity, saw the quarter's year-over-year revenue decrease by roughly 67%, from $300,000 in 2019 to $100,000. The first quarter of 2020 showed a significant decline compared to the same period in the last year. Evogene has been struggling for months as its fourth quarter financial update reported downturns as well. Here's a breakdown of what the earnings report for the first quarter showed: Gross profit was $36 000, compared to a gross … Full story available on Benzinga.com
   Evogene Reports First Quarter 2020 Financial Results  2020/05/26 11:00:00 PR Newswire
REHOVOT, Israel, May 26, 2020 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading computational biology company targeting to revolutionize life-science product development across several market segments, announced today its financial results for the first quarter, ended…
   Evogene : Launches its New Branding to Reflect the Company's Expanded Vision and New Business Model | MarketScreener  2020/05/20 11:19:09 MarketScreener
Rehovot, Israel - May 20, 2020- Evogene Ltd. , a leading computational biology company targeting to revolutionize life-science product development across several market segments,… | May 20, 2020

 関連キーワード  (― 米国株 エボジェン EVGN Evogene Ltd.)

 twitter  (公式ツイッターやCEOツイッターなど)